Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

被引：1197

作者：

Robertson, A. Gordon ^{[1
]}

Kim, Jaegil ^{[2
]}

Al-Ahmadie, Hikmat ^{[3
]}

Bellmunt, Joaquim ^{[4
,5
]}

Guo, Guangwu ^{[5
,6
]}

Cherniack, Andrew D. ^{[2
]}

Hinoue, Toshinori ^{[7
]}

Laird, Peter W. ^{[7
]}

Hoadley, Katherine A. ^{[8
]}

Akbani, Rehan ^{[9
]}

Castro, Mauro A. A. ^{[10
]}

Gibb, Ewan A. ^{[1
]}

Kanchi, Rupa S. ^{[9
]}

Gordenin, Dmitry A. ^{[11
]}

Shukla, Sachet A. ^{[5
,6
]}

Sanchez-Vega, Francisco ^{[12
]}

Hansel, Donna E. ^{[13
]}

Czerniak, Bogdan A. ^{[14
]}

Reuter, Victor E. ^{[3
]}

Su, Xiaoping ^{[9
]}

Carvalho, Benilton de Sa ^{[15
]}

Chagas, Vinicius S. ^{[10
]}

Mungall, Karen L. ^{[1
]}

Sadeghi, Sara ^{[1
]}

Pedamallu, Chandra Sekhar ^{[2
]}

Lu, Yiling ^{[16
]}

Klimczak, Leszek J. ^{[17
]}

Zhang, Jiexin ^{[9
]}

Choo, Caleb ^{[1
]}

Ojesina, Akinyemi I. ^{[18
]}

Bullman, Susan ^{[2
]}

Leraas, Kristen M. ^{[19
]}

Lichtenberg, Tara M. ^{[19
]}

Wu, Catherine J. ^{[20
]}

Schultz, Nicholaus ^{[12
]}

Getz, Gad ^{[2
]}

Meyerson, Matthew ^{[5
,21
]}

Mills, Gordon B. ^{[16
]}

McConkey, David J. ^{[22
]}

Weinstein, John N. ^{[9
,16
]}

Kwiatkowski, David J. ^{[23
]}

Lerner, Seth P. ^{[24
]}

机构：

[1] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada

[2] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02142 USA

[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA

[4] Dana Farber Canc Inst, Bladder Canc Ctr, Dept Med, PSMAR IMIM Lab, Boston, MA 02215 USA

[5] Harvard Univ, Boston, MA 02115 USA

[6] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[7] Van Andel Res Inst, Ctr Epigenet, Grand Rapids, MI 49503 USA

[8] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27514 USA

[9] Univ Texas Houston, MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA

[10] Univ Fed Parana, Polytech Ctr, Bioinformat & Syst Biol Lab, BR-80060000 Curitiba, Parana, Brazil

[11] NIEHS, NIH, Genome Integr & Struct Biol Lab, POB 12233, Res Triangle Pk, NC 27709 USA

[12] Mem Sloan Kettering Canc Ctr, Ctr Mol Oncol, New York, NY 10065 USA

[13] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA

[14] Univ Texas Houston, MD Anderson Canc Ctr, Dept Pathol, 1515 Holcombe Blvd, Houston, TX 77030 USA

[15] Univ Estadual Campinas, Dept Stat, Biostat & Computat Biol Lab, BR-13083859 Sao Paulo, Brazil

[16] Univ Texas Houston, MD Anderson Canc Ctr, Dept Syst Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA

[17] NIEHS, NIH, Integrat Bioinformat Support Grp, POB 12233, Res Triangle Pk, NC 27709 USA

[18] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA

[19] Res Inst Nationwide Childrens Hosp, Biospecimen Core Resource, Columbus, OH 43205 USA

[20] Harvard Med Sch, Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Med Oncol, 75 Francis St, Boston, MA 02115 USA

[21] Dana Farber Canc Inst, Pathol & Med Oncol, Boston, MA 02115 USA

[22] Johns Hopkins Univ, Greenberg Bladder Canc Inst, Baltimore, MD 21218 USA

[23] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA

[24] Baylor Coll Med, Dan L Duncan Canc Ctr, Scott Dept Urol, Houston, TX 77030 USA

来源：

CELL | 2017年 / 171卷 / 03期

关键词：

SOMATIC ERCC2 MUTATIONS; PHASE PROTEIN ARRAY; UROTHELIAL CARCINOMA; GENETIC ALTERATIONS; LUMINAL SUBTYPES; EXPRESSION; RECEPTOR; ACCURATE; BASAL; QUANTIFICATION;

D O I：

10.1016/j.cell.2017.09.007

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

We report a comprehensive analysis of 412 muscleinvasive bladder cancers characterized by multiple TCGA analytical platforms. Fifty-eight genes were significantly mutated, and the overall mutational load was associated with APOBEC-signature mutagenesis. Clustering by mutation signature identified a high-mutation subset with 75% 5-year survival. mRNA expression clustering refined prior clustering analyses and identified a poor-survival "neuronal'' subtype in which the majority of tumors lacked small cell or neuroendocrine histology. Clustering by mRNA, long non-coding RNA ( lncRNA), and miRNA expression converged to identify subsets with differential epithelial-mesenchymal transition status, carcinoma in situ scores, histologic features, and survival. Our analyses identified 5 expression subtypes that may stratify response to different treatments.

引用

页码：540 / +

页数：42

共 50 条

[31] Optimal management of muscle-invasive bladder cancer - a review
Scarpato, Kristen R.
Morgans, Alicia K.
Moses, Kelvin A.
RESEARCH AND REPORTS IN UROLOGY, 2015, 7 : 143 - 151
[32] Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer
Katayama, Satoshi
Schuettfort, Victor M.
Pradere, Benjamin
Mori, Keiichiro
Mostafaei, Hadi
Quhal, Fahad
Motlagh, Reza Sari
Laukhtina, Ekaterina
Grossmann, Nico C.
Aydh, Abdulmajeed
Rajwa, Pawel
Koenig, Frederik
Karakiewicz, Pierre, I
Haydter, Martin
Moschini, Marco
Abufaraj, Mohammad
Lotan, Yair
Lee, Richard K.
Quoc-Dien Trinh
Comperat, Eva
Teoh, Jeremy
Nasu, Yasutomo
Shariat, Shahrokh F.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (11) : 3091 - 3102
[33] Treatment of muscle-invasive bladder cancer: A systematic review
Chou, Roger
Selph, Shelley S.
Buckley, David I.
Gustafson, Katie S.
Griffin, Jessica C.
Grusing, Sara E.
Gore, John L.
CANCER, 2016, 122 (06) : 842 - 851
[34] Mouse Models of Muscle-invasive Bladder Cancer: Key Considerations for Clinical Translation Based on Molecular Subtypes
Ruan, Jia-Ling
Hsu, Jong-Wei
Browning, Richard J.
Stride, Eleanor
Yildiz, Yesna O.
Vojnovic, Borivoj
Kiltie, Anne E.
EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (03): : 239 - 247
[35] Bladder-Sparing Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer
Ericson, Kyle J.
Murthy, Prithvi B.
Bryk, Darren J.
Ramkumar, Rathika R.
Broughman, James R.
Khanna, Abhinav
Mian, Omar Y.
Campbell, Steven C.
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (12) : 697 - 707
[36] The role of biomarkers in bladder preservation management of muscle-invasive bladder cancer
Mitin, Timur
Choudhury, Ananya
WORLD JOURNAL OF UROLOGY, 2019, 37 (09) : 1767 - 1772
[37] Molecular profiling in muscle-invasive bladder cancer: more than the sum of its parts
Sjodahl, Gottfrid
Jackson, Chelsea L.
Bartlett, John M. S.
Siemens, D. Robert
Berman, David M.
JOURNAL OF PATHOLOGY, 2019, 247 (05) : 563 - 573
[38] Updates for the radiologist in non-muscle-invasive, muscle-invasive, and metastatic bladder cancer
Jooae Choe
Marta Braschi-Amirfarzan
Sree Harsha Tirumani
Atul B. Shinagare
Kyung Won Kim
Nikhil H. Ramaiya
Katherine M. Krajewski
Abdominal Radiology, 2017, 42 : 2710 - 2724
[39] Updates for the radiologist in non-muscle-invasive, muscle-invasive, and metastatic bladder cancer
Choe, Jooae
Braschi-Amirfarzan, Marta
Tirumani, Sree Harsha
Shinagare, Atul B.
Kim, Kyung Won
Ramaiya, Nikhil H.
Krajewski, Katherine M.
ABDOMINAL RADIOLOGY, 2017, 42 (11) : 2710 - 2724
[40] Comprehensive pathological assessment of histological subtypes, molecular subtypes based on immunohistochemistry, and tumor-associated immune cell status in muscle-invasive bladder cancer
Ikeda, Junichi
Ohe, Chisato
Yoshida, Takashi
Kuroda, Naoto
Saito, Ryoichi
Kinoshita, Hidefumi
Tsuta, Koji
Matsuda, Tadashi
PATHOLOGY INTERNATIONAL, 2021, 71 (03) : 173 - 182

← 1 2 3 4 5 →